

iwCAR-T Session III: CAR-T therapy in AML: ongoing challenges and strategies to improve patient outcomes
May 24, 2023
Experts discuss challenges in CAR-T therapy for AML, strategies to improve patient outcomes, integrating CAR-T cells into stem cell approach, targeting leukemia stem cells, challenges with T-cell fitness, impact of target antigens on T-cell exhaustion, collaboration, bias towards NK cells, optimism for improving leukemia treatment
Chapters
Transcript
Episode notes